BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11244490)

  • 21. Lack of association between the brain-derived neurotrophin factor (C-270T) polymorphism and late-onset Alzheimer's disease (LOAD) in Brazilian patients.
    Nishimura AL; Oliveira JR; Mitne-Neto M; Guindalini C; Nitrini R; Bahia VS; de Brito-Marques PR; Otto PA; Zatz M
    J Mol Neurosci; 2004; 22(3):257-60. PubMed ID: 14997020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No association between the brain-derived neurotrophic factor 196 G>A or 270 C>T polymorphisms and Alzheimer's or Parkinson's disease.
    Saarela MS; Lehtimaki T; Rinne JO; Huhtala H; Rontu R; Hervonen A; Roytta M; Ahonen JP; Mattila KM
    Folia Neuropathol; 2006; 44(1):12-6. PubMed ID: 16565926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of oxidized LDL-receptor 1 (OLR1) as the candidate gene for Alzheimer's disease on chromosome 12.
    Luedecking-Zimmer E; DeKosky ST; Chen Q; Barmada MM; Kamboh MI
    Hum Genet; 2002 Oct; 111(4-5):443-51. PubMed ID: 12384789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.
    Capurso C; Solfrizzi V; Colacicco AM; D'Introno A; Frisardi V; Imbimbo BP; Lorusso M; Vendemiale G; Denitto M; Santamato A; Seripa D; Pilotto A; Fiore P; Capurso A; Panza F
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):177-82. PubMed ID: 19897004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic analysis of BDNF and TrkB gene polymorphisms in Alzheimer's disease.
    Vepsäläinen S; Castren E; Helisalmi S; Iivonen S; Mannermaa A; Lehtovirta M; Hänninen T; Soininen H; Hiltunen M
    J Neurol; 2005 Apr; 252(4):423-8. PubMed ID: 15726264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
    Cui T; Zhou X; Jin W; Zheng F; Cao X
    Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic variation in the brain derived neurotrophic factor gene in Alzheimer's disease.
    Bodner SM; Berrettini W; van Deerlin V; Bennett DA; Wilson RS; Trojanowski JQ; Arnold SE
    Am J Med Genet B Neuropsychiatr Genet; 2005 Apr; 134B(1):1-5. PubMed ID: 15635706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The -491 A/T polymorphism in the regulatory region of the apolipoprotein E gene and early-onset Alzheimer's disease.
    Roks G; Cruts M; Bullido MJ; Backhovens H; Artiga MJ; Hofman A; Valdivieso F; Van Broeckhoven C; Van Duijn CM
    Neurosci Lett; 1998 Dec; 258(2):65-8. PubMed ID: 9875528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease.
    Lehmann DJ; Johnston C; Smith AD
    Hum Mol Genet; 1997 Oct; 6(11):1933-6. PubMed ID: 9302273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of association between the BDNF gene Val66Met polymorphism and Alzheimer disease in a Chinese Han population.
    He XM; Zhang ZX; Zhang JW; Zhou YT; Tang MN; Wu CB; Hong Z
    Neuropsychobiology; 2007; 55(3-4):151-5. PubMed ID: 17657167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Val66Met Polymorphism in BDNF Has No Sexual and APOE ε4 Status-Based Dimorphic Effects on Susceptibility to Alzheimer's Disease: Evidence From an Updated Meta-Analysis of Case-Control Studies and High-Throughput Genotyping Cohorts.
    Zhao Q; Shen Y; Zhao Y; Si L; Jiang S; Qiu Y;
    Am J Alzheimers Dis Other Demen; 2018 Feb; 33(1):55-63. PubMed ID: 28984138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic association studies between Alzheimer's disease and two polymorphisms in the low density lipoprotein receptor-related protein gene.
    Kamboh MI; Ferrell RE; DeKosky ST
    Neurosci Lett; 1998 Mar; 244(2):65-8. PubMed ID: 9572586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sexually dimorphic effect of the Val66Met polymorphism of BDNF on susceptibility to Alzheimer's disease: New data and meta-analysis.
    Fukumoto N; Fujii T; Combarros O; Kamboh MI; Tsai SJ; Matsushita S; Nacmias B; Comings DE; Arboleda H; Ingelsson M; Hyman BT; Akatsu H; Grupe A; Nishimura AL; Zatz M; Mattila KM; Rinne J; Goto Y; Asada T; Nakamura S; Kunugi H
    Am J Med Genet B Neuropsychiatr Genet; 2010 Jan; 153B(1):235-42. PubMed ID: 19504537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel mutation in the apolipoprotein E gene (APOE*4 Pittsburgh) is associated with the risk of late-onset Alzheimer's disease.
    Kamboh MI; Aston CE; Perez-Tur J; Kokmen E; Ferrell RE; Hardy J; DeKosky ST
    Neurosci Lett; 1999 Mar; 263(2-3):129-32. PubMed ID: 10213152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.
    Lehtovirta M; Soininen H; Helisalmi S; Mannermaa A; Helkala EL; Hartikainen P; Hänninen T; Ryynänen M; Riekkinen PJ
    Neurology; 1996 Feb; 46(2):413-9. PubMed ID: 8614504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein E polymorphism and susceptibility to early- and late-onset sporadic Alzheimer's disease in Hokkaido, the northern part of Japan.
    Nunomura A; Chiba S; Eto M; Saito M; Makino I; Miyagishi T
    Neurosci Lett; 1996 Mar; 206(1):17-20. PubMed ID: 8848271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [ACT/AA polymorphism could duplicate the APOE*epsilon4-associated Alzheimer's disease risk].
    Hernández-Charro B; Moreno S; Valiente A; Manubens JM; Villar MD; Ramos-Arroyo MA
    Med Clin (Barc); 2004 Sep; 123(7):251-4. PubMed ID: 15482730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression.
    Caraci F; Bosco P; Signorelli M; Spada RS; Cosentino FI; Toscano G; Bonforte C; Muratore S; Prestianni G; Panerai S; Giambirtone MC; Gulotta E; Romano C; Salluzzo MG; Nicoletti F; Copani A; Drago F; Aguglia E; Ferri R
    Eur Neuropsychopharmacol; 2012 Apr; 22(4):281-9. PubMed ID: 21924590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
    Corder EH; Saunders AM; Strittmatter WJ; Schmechel DE; Gaskell PC; Small GW; Roses AD; Haines JL; Pericak-Vance MA
    Science; 1993 Aug; 261(5123):921-3. PubMed ID: 8346443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence.
    Zhang H; Ozbay F; Lappalainen J; Kranzler HR; van Dyck CH; Charney DS; Price LH; Southwick S; Yang BZ; Rasmussen A; Gelernter J
    Am J Med Genet B Neuropsychiatr Genet; 2006 Jun; 141B(4):387-93. PubMed ID: 16649215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.